You are here:Boll&Holl International vision - Friday, 21 January 2022
January
London, United Kingdom– Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has entered into a license agreement with Medicine Patent Pool (MPP) for molnupiravir, MSD’s investigational oral COVID-19 antiviral medicine, in the Middle East and North Africa (MENA) region.
January
Alturki builds on its commitment to localization by participating in the 2022 IKTVA Forum and Exhibition as a Diamond Sponsor
Published in Economic development
Dhahran, Saudi Arabia: Alturki Holding has committed to participate in the next IKTVA Forum and Exhibition as a Diamond Sponsor.
January
Togo - European Union New Partnership Framework and Renewed Financial Commitment
Published in Economic development
LOMÉ, Togo- An official ceremony to present and launch the 2021-2027 Joint Multiyear Programming Document (DCP) was held in Lomé on January12 at the 2022,headquarters of the Ministry of Planning, Development and Cooperation.
